CN113384475A - Toning lotion - Google Patents
Toning lotion Download PDFInfo
- Publication number
- CN113384475A CN113384475A CN202010165397.5A CN202010165397A CN113384475A CN 113384475 A CN113384475 A CN 113384475A CN 202010165397 A CN202010165397 A CN 202010165397A CN 113384475 A CN113384475 A CN 113384475A
- Authority
- CN
- China
- Prior art keywords
- attapulgite
- lotion
- alcohol
- oil
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 52
- 229960000892 attapulgite Drugs 0.000 claims abstract description 57
- 229910052625 palygorskite Inorganic materials 0.000 claims abstract description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- 150000003839 salts Chemical class 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 23
- 239000012071 phase Substances 0.000 claims description 56
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000008346 aqueous phase Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 16
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 16
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 7
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 7
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 7
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 229960005323 phenoxyethanol Drugs 0.000 claims description 7
- 229940113120 dipropylene glycol Drugs 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000001509 sodium citrate Substances 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- 229960005150 glycerol Drugs 0.000 claims description 4
- 239000008341 cosmetic lotion Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 239000002537 cosmetic Substances 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 239000002244 precipitate Substances 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 51
- 210000003491 skin Anatomy 0.000 description 26
- 238000010521 absorption reaction Methods 0.000 description 15
- 239000002994 raw material Substances 0.000 description 15
- 238000003756 stirring Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 8
- 238000004062 sedimentation Methods 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 6
- 239000000440 bentonite Substances 0.000 description 5
- 229910000278 bentonite Inorganic materials 0.000 description 5
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 5
- 239000004927 clay Substances 0.000 description 5
- 238000007599 discharging Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000005995 Aluminium silicate Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000012211 aluminium silicate Nutrition 0.000 description 4
- 230000032798 delamination Effects 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 206010039792 Seborrhoea Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 229940069078 citric acid / sodium citrate Drugs 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000037312 oily skin Effects 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 229920000832 Cutin Polymers 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 208000020154 Acnes Diseases 0.000 description 1
- ABLUTJHTTUXSOU-UHFFFAOYSA-L C(C)(=O)[O-].S(=O)(=O)([O-])[O-].[Ca+2].[NH4+] Chemical compound C(C)(=O)[O-].S(=O)(=O)([O-])[O-].[Ca+2].[NH4+] ABLUTJHTTUXSOU-UHFFFAOYSA-L 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Chemical group CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Chemical group CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical group O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000005837 radical ions Chemical class 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000011863 silicon-based powder Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/34—Free of silicones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a lotion, which comprises a powder phase and a water phase, wherein the powder phase is attapulgite, the water phase mainly comprises water, and can also comprise alcohol, salt and the like, and the contents of the alcohol, the alcohol and the salt are respectively 0.5-4.5% of the attapulgite, 5-15% of the alcohol and 0.05-0.2% of the salt. The toning lotion can quickly form layering when standing, precipitates which are placed for a long time are not hardened, the toning lotion can be uniformly dispersed by gently shaking during use, and the toning lotion is wiped and coated on the surface of skin and has the effect of adsorbing oil, so that the oil control effect is mainly water, the toning lotion does not contain oil components, the oil control is mild, the oil control effect is good, the oil on the surface of the skin is adsorbed, and the toning lotion has excellent dry and smooth feeling and is very excellent, and the variety of cosmetics selected by consumers is enriched. In addition, the invention also discloses the application of the attapulgite in the preparation of the skin oil control reagent.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a toning lotion, and especially relates to a rapid layering oil control toning lotion containing attapulgite.
Background
Attapulgite is clay mineral with water-containing magnesium-rich silicate as main component and has the advantages of smooth feeling, light weight, high water absorption, no swelling in water, and high viscosity and plasticity in wet condition. The attapulgite has a large number of zeolite pore canals inside and grooves at intervals between concave and convex surfaces, so that the attapulgite has large specific surface area and strong adsorption capacity, and the internal surface area can reach 300-400 m2Per g, exterior surfaceArea of about 23m2Adsorbing chromium-containing wastewater by using attapulgite clay]Chemical environmental protection, 1989, 9 (4): 248-249.]. The attapulgite clay is used as an inorganic mineral material which is cheap and easy to obtain, has very abundant reserves in China, has more excellent performances compared with other natural materials, is simple in preparation process and special in structure, and has great potential in the aspect of cosmetic application.
The skin is the largest organ of the human body, and is composed of epidermis, dermis and subcutaneous tissue, and contains accessory organs including sweat glands, sebaceous glands, blood vessels, and the like. The oily skin people refer to a part of people with greasy face caused by the fact that the secretion function of sebaceous glands is vigorous. Too much grease can cause gloss on the face, is not easy to clean and affects the beauty; the secretion of oil and fat can also bring about the breeding of microorganisms, so that acne appears on the face, which is also the reason why many products take oil control and acne removal as main propaganda slogans. In addition, the oil secretion is excessive, pores are enlarged by the accumulated oil, and the large pores are also a great problem which troubles the oily skin. Controlling the excessive secretion of sebaceous glands and relieving the oil production symptoms are the key points for keeping the skin healthy.
At present, skin care products for solving the problem of oily skin generally have two ways, namely, the oil control effect is achieved by physical adsorption such as silicon powder and PE powder and by changing the physiological characteristics of the skin, and for example, the function of controlling oil and removing acnes is achieved by the alpha-carboxylic acid raw materials through bacteriostasis and exfoliating cutin. However, acid products tend to disrupt the stratum corneum, causing skin sensitivity, and more people with sensitive skin need milder oil control products. The metabolic turnover of skin cells is typically 28 days, and the effects of altering the physiological properties of the skin generally require prolonged continuous use to achieve the desired effect. Synthetic chemical particulate materials such as PE powder can enter the human body through the respiratory or food chain, endangering human health and also affecting the ecological environment. In addition, with the deep mind of the concept of 'no silicone oil', the adsorption product without silicone oil can generate positive effects and better adapt to consumption requirements.
In addition, a type of cosmetic containing a powder component and capable of redispersing the powder component by shaking at the time of use, that is, a type of redispersible powder-dispersed cosmetic is known. Patent publication No. CN104093393B discloses that a re-dispersible powder dispersion cosmetic prepared mainly from bentonite and succinic acid, etc., is mainly used for removing keratotic plugs from the skin, is not satisfactory in oil control effect, and is not suitable for the preparation of a rapidly layered oil control lotion, although it gives a pleasant feel even when it is applied to the skin.
Disclosure of Invention
In order to solve the problems, the invention provides the toning lotion.
The cosmetic water comprises a powder phase and a water phase, wherein the powder phase is attapulgite, and the main component of the water phase is water.
Further, the aqueous phase also comprises alcohol.
Further, the alcohol is dideal alcohol.
Further, the aqueous phase may also contain both alcohol and salt.
Further, the salt is NaCl.
Further, the content of attapulgite in the toning lotion is 0.5-4.5%, the content of alcohol is 5-15%, and the content of salt is 0.05-0.2%.
Further, the aqueous phase may further comprise one or more of EDTA-2Na, glycerol, dipotassium glycyrrhizinate, dipropylene glycol, and phenoxyethanol.
Further, the water phase may further comprise one or more of 0.05% of EDTA-2Na, 3% of glycerol, 0.05% of dipotassium glycyrrhizinate, 1% of dipropylene glycol, and 0.5% of phenoxyethanol.
Further, the water phase also comprises one or more of sodium hyaluronate, citric acid and sodium citrate.
Further, the aqueous phase further comprises one or more of 0.1% sodium hyaluronate, 0.02% citric acid, 0.3% sodium citrate.
Another aspect of the present invention is to find the use of attapulgite in the manufacture of a skin oil control agent, the attapulgite having a remarkable effect in adsorbing oil on the skin surface due to its own specific properties.
Further, the attapulgite is used for preparing the skin oil control agent, and the agent comprises a powder phase and a water phase, wherein the powder phase is attapulgite, and the main component of the water phase is water.
Further, the use of attapulgite in the manufacture of a skin oil control agent, the aqueous phase of which also comprises alcohol.
Further, the use of attapulgite for the manufacture of a skin oil control agent, the aqueous phase of which also comprises a salt.
Further, the use of attapulgite in the preparation of a skin oil control agent comprises the attapulgite with the content of 0.5-4.5%, alcohol with the content of 5-15% and salt with the content of 0.05-0.2%.
Further, the attapulgite is used for manufacturing the skin oil control agent, and the water phase of the agent can also contain one or more of EDTA-2Na, glycerol, dipotassium glycyrrhizinate, dipropylene glycol and phenoxyethanol.
Further, the attapulgite is used for preparing the skin oil control agent, and the water phase of the agent can also comprise one or more of 0.05 percent of EDTA-2Na, 3 percent of glycerin, 0.05 percent of dipotassium glycyrrhizinate, 1 percent of dipropylene glycol and 0.5 percent of phenoxyethanol.
Further, the attapulgite is used for manufacturing the skin oil control agent, and the water phase of the agent also comprises one or more of sodium hyaluronate, citric acid and sodium citrate.
Further, the attapulgite is used for manufacturing the skin oil control agent, and the water phase of the agent also comprises one or more of 0.1% of sodium hyaluronate, 0.02% of citric acid and 0.3% of sodium citrate.
The invention provides a toning lotion which can quickly form layering (about 4min at the fastest) when standing, precipitates are not hardened after long-term storage, the toning lotion can be uniformly dispersed by slight shaking when being used, and the toning lotion has the function of absorbing grease when being smeared on the surface of skin, so that the oil control effect is achieved. In addition, the invention also discloses the application of the attapulgite in the preparation of the skin oil control reagent.
Drawings
FIG. 1 is a crystal structure diagram of attapulgite
FIG. 2 is a photograph showing the state of a sample after shaking it uniformly and then left standing for 4 minutes in the sedimentation velocity-affecting test in example 7
FIG. 3 is a photograph showing the state of a sample which was shaken uniformly and then left to stand for 10 minutes in the sedimentation velocity-affecting test in example 7
Detailed Description
The present invention is described in further detail below with reference to examples, which are intended to facilitate the understanding of the present invention without limiting it in any way.
The rapid layering oil control toning lotion containing attapulgite is characterized by mainly being a water agent and not containing oil components, and the toning lotion contains a powder phase and a water phase, wherein the powder phase is mainly the attapulgite; the water phase may contain alcohol, salt, and other components capable of being used as matrix and having effects of moistening and regulating skin feeling, such as EDTA-2Na, glycerol, dipotassium glycyrrhizinate, dipropylene glycol, phenoxyethanol, etc.
The ideal chemical formula of attapulgite is: mg (magnesium)5Si8O20(OH)2(OH2)4·4H2O, crystal structure as shown in fig. 1, in each of 2: in the 1 unit structure layer, the tetrahedral wafer angle tops are reversed at a certain distance to form a layer chain. The attapulgite clay after selection has excellent smoothness, adhesion and air permeability as raw materials of cosmetics, and is especially suitable for cosmetics such as foundation blush, face powder, eyebrow, lipstick, etc. The porous fragrance material is used to soak aromatic substances (essence and perfume) in soil to prepare the slow-release aromatic with stable and sustained fragrance release for more than 6 months. The toning lotion provided by the invention innovatively adopts attapulgite as a main raw material, and makes full use of the characteristics of smooth feeling, light weight, strong water absorption, no expansion when meeting water, viscosity and plasticity when wet, and large specific surfaceThe lotion has a large volume and strong adsorption force, and has a remarkable effect on oil control and skin care, so that the lotion has a stronger market competitive advantage.
The alcohol can be classified into common edible alcohol, single dealdehydized alcohol or double dealdehydized alcohol, etc. The aldehyde content of the single dealdehydized alcohol or the double dealdehydized alcohol is lower than that of the second-level daily-use alcohol, the single dealdehydized alcohol or the double dealdehydized alcohol has no strong pungent smell, is a product deeply processed by the second-level edible alcohol, has the characteristic of lower pungent smell than that of common edible alcohol, is widely used in products such as shampoo, toilet water, perfume, spice and the like, is an ideal raw material for replacing import in the chemical industry, is a basic raw material for producing high-grade daily-use chemical products, and has the density of 75-90 percent of dealdehydized alcohol between 0.85 and 0.793. The toning lotion is preferably double dealdehydized alcohol, has no pungent smell, has the effect of promoting the absorption of nutrient components, is higher in grade, and is more easily accepted by wide consumers.
The salt refers to a metal ion or ammonium ion (NH)4+) The compound combined with acid radical ion (or nonmetal ion) such as sodium chloride, sodium carbonate, calcium nitrate, ferrous sulfate, ammonium calcium sulfate acetate, copper chloride, potassium chloride, sodium acetate, etc. generally, the salt is the product of double decomposition reaction, the salt reacts with salt to generate new salt and new salt, the salt reacts with alkali to generate new salt and new alkali, the salt reacts with acid to generate new salt and new acid, such as sulfuric acid and sodium hydroxide to generate sodium sulfate and water, the sodium chloride reacts with silver nitrate to generate silver chloride and sodium nitrate, etc., and other reactions can generate salt, such as displacement reaction, the solution of soluble salt has conductivity, because the solution has free swimming ion, can be used as electrolyte, and is one kind of crystal. The salt in the toning lotion is preferably NaCl, so that grease and acne accumulated in facial pores and cutin and dirt on the surface of skin can be eliminated, and the oil control effect of the toning lotion can be improved.
The attapulgite-containing rapid oil-control astringent of the present invention can be suitably blended with various components, such as powder components, moisturizers, thickeners, metal ion masking agents, pigments, pH adjusters, skin nutrients, vitamins, preservatives, antioxidants, antioxidant aids, perfumes, etc., which are generally blended in the fields of cosmetics and quasi drugs, as needed, within the range that does not impair the effects of the present invention.
Example 1 Attapulgite oil absorption Performance test
An oil absorption test is carried out by referring to a method for measuring an oil absorption value of a plum blossom (Li blossom, Chang, Cheng Peak) and high-purity silicon micro powder [ J ]. school news of national university in southwest (Nature science edition), 2005,31(3):377-379 ], and dimethyl silicone oil (the model is KF-96A-6CS) with the viscosity of 6CS is selected by taking low viscosity and easy accessibility of laboratories as main factors when oil is selected.
Accurately weighing 10.00g of each sample of kaolin, bentonite and attapulgite (the three samples are selected with the particle size of 40 mu m), placing the sample on a glass plate, quickly dripping 5-6g of simethicone at first, fully blending by a stirring shovel in the dripping process to enable oil to be uniformly infiltrated with all powder particles, then continuously dripping while grinding and pressing, dripping gradually when the end point is approached, fully grinding and pressing every drop, and recording the consumed oil amount when the sample and the oil are bonded into a paste which is not cracked and has no oil marks on the glass plate. All operations should be completed within 15 min. The oil absorption is expressed in mass of dimethicone required per 100g of sample. Three replicates were performed, and the results are shown in the following table, averaged:
test sample | Oil absorption g/100g |
Kaolin clay | 77.5g |
Bentonite clay | 83.2g |
Attapulgite | 109.0g |
The oil absorption value is related to the size and shape, the specific surface area and the surface properties of the powder particles, so the oil absorption value measurement is an effective method for evaluating the surface chemical properties of the powder. According to the experimental result, the oil absorption capacity of the attapulgite is far better than that of bentonite and kaolin under the condition of the same particle size, and the attapulgite is more suitable for preparing oil-control toning lotion.
Analysis of variance: through repeated experiments, the variance analysis is carried out on the experimental data, and the oil absorption values of the attapulgite, the kaolin and the bentonite are found to be very different (the P value is less than 0.01) (the specific data is not shown).
Example 2
The ingredients required to formulate the lotion were divided into A, B, C, D, E, F six phases, as shown in the following table:
phase A is used as matrix, and has effects of keeping moisture and regulating skin feeling, and phase B, C, D, E, F is the main ingredient of cosmetic water. In this embodiment, A, B, C phases in the table above are used to prepare the attapulgite-containing astringent for quickly layering and controlling oil, and the preparation method specifically comprises: sequentially adding the phase A raw materials into a main pot, heating to 50-55 ℃ under the condition of stirring, and opening to cool to 25 ℃ after the phase A raw materials are completely dissolved and uniformly mixed; adding phase B into the main boiler; and C phase: adding water into the attapulgite, fully and uniformly mixing, and adding into a main pot; fully stirring and discharging.
Example 3
In this example, A, B, C, D four phases in the table of example 2 are adopted to prepare the attapulgite-containing fast layering oil-control lotion, and the preparation method specifically comprises the following steps: sequentially adding the phase A raw materials into a main pot, heating to 50-55 ℃ under the condition of stirring, and opening to cool to 25 ℃ after the phase A raw materials are completely dissolved and uniformly mixed; adding phase B into the main boiler; and C phase: adding water into the attapulgite, fully and uniformly mixing, and adding into a main pot; phase D: adding water into sodium hyaluronate for soaking, heating to 85 ℃, starting stirring until the sodium hyaluronate is completely dissolved, cooling to 25 ℃, and adding into a main pot; fully stirring and discharging.
Example 4
In this example, A, B, C, E four phases in the table of example 2 are adopted to prepare the attapulgite-containing fast layering oil-control lotion, and the preparation method specifically comprises the following steps: sequentially adding the phase A raw materials into a main pot, heating to 50-55 ℃ under the condition of stirring, and opening to cool to 25 ℃ after the phase A raw materials are completely dissolved and uniformly mixed; adding phase B into the main boiler; and C phase: adding water into the attapulgite, fully and uniformly mixing, and adding into a main pot; adding the dissolved E phase into a main boiler; fully stirring and discharging.
Example 5
In this example, A, B, C, D, E phases in the table of example 2 are adopted to prepare the attapulgite-containing fast layering oil-control lotion, and the preparation method specifically comprises the following steps: sequentially adding the phase A raw materials into a main pot, heating to 50-55 ℃ under the condition of stirring, and opening to cool to 25 ℃ after the phase A raw materials are completely dissolved and uniformly mixed; adding phase B into the main boiler; and C phase: adding water into the attapulgite, fully and uniformly mixing, and adding into a main pot; phase D: adding water into sodium hyaluronate for soaking, heating to 85 ℃, starting stirring until the sodium hyaluronate is completely dissolved, cooling to 25 ℃, and adding into a main pot; adding the dissolved E phase into a main boiler; fully stirring and discharging.
Example 6
In this example, A, B, C, F phases in the table of example 2 are adopted to prepare the attapulgite-containing fast layering oil-control lotion, and the preparation method specifically comprises the following steps: sequentially adding the phase A raw materials into a main pot, heating to 50-55 ℃ under the condition of stirring, and opening to cool to 25 ℃ after the phase A raw materials are completely dissolved and uniformly mixed; adding phase B into the main boiler; and C phase: adding water into the attapulgite, fully and uniformly mixing, and adding into a main pot; phase D: adding water into sodium hyaluronate for soaking, heating to 85 ℃, starting stirring until the sodium hyaluronate is completely dissolved, cooling to 25 ℃, and adding into a main pot; adding the dissolved E phase into a main boiler; fully stirring and discharging.
Example 7 sedimentation velocity Effect experiment
Using the lotions prepared in examples 2 to 6, sedimentation rate-affecting experiments were conducted to summarize the formulations in each example as shown in the following table, "+" indicates addition and "-" indicates no addition.
The state of the sample after shaking uniformly and standing for 4 minutes is shown in FIG. 2, and the state of the sample after standing for 10 minutes is shown in FIG. 3. As can be seen from examples 2 and 3, the addition of a thickening agent such as sodium hyaluronate slows down the deposition and the time required to form a significant delamination is extended from 10min to 146min, probably because: the sedimentation difficulty is increased along with the increase of the viscosity of the water aqua, and the sedimentation speed is reduced; according to examples 2 and 4, the addition of pH modifiers such as citric acid/sodium citrate will slow down the deposition, extending the time required to form a significant layer separation from 10min to 29min, probably due to: the citric acid/sodium citrate is combined with hydroxyl at the edge of the attapulgite crystal, so that the edge of the wafer becomes more free, the positive charge edge and the negative charge crystal face interact, the mobility of the wafer in the solution is reduced, and the rapid delamination is not facilitated; from examples 3 and 5, it can be seen that the time required for significant delamination is reduced from 146min to 92min by adding sodium hyaluronate and pH adjuster simultaneously, probably because: the basic structure of the sodium hyaluronate is a large polysaccharide consisting of two disaccharide units of D-glucuronic acid and N-acetylglucosamine, a large number of hydroxyl groups are distributed in molecules, and the addition of the citric acid/sodium citrate is combined with the sodium hyaluronate, so that the combination with the hydroxyl groups at the edge of the attapulgite crystal is reduced competitively, and the phenomenon that the sedimentation speed is increased is shown; as can be seen from examples 2 and 6, the addition of sodium chloride increased the settling rate and reduced the time required to form significant stratification from 10min to 4min, possibly due to: the attapulgite crystal edge has a small amount of local positive charges due to the absorption of hydroxyl, and the osmotic pressure from an aqueous medium of the solution after the salt is added can improve the mobility of the wafer, thereby meeting the requirement of rapid delamination of the invention. Therefore, the sedimentation rate is the fastest, and the preferred embodiment 6 (the time required for forming a significant layer is 4min) for realizing rapid layer separation is that the optimal components of the rapid layer separation oil control toning lotion are 0.5-4.5% of attapulgite, 5-15% of alcohol and 0.05-0.2% of salt.
Example 8: volunteer preference evaluation
The lotions prepared in examples 2 and 6 (hereinafter, referred to as No. 2 and No. 6) were distributed to volunteers to test the oil absorption performance of the lotions of the present invention, and the volunteers' preference for the present invention.
The investigation method comprises the following steps: 15 female volunteers between 20-40 years old have obvious oil on skin, use the lotion after washing face with clear water every night as required under the condition of no make-up, stand for 5 minutes before use, observe the state of the sample to fill in preference, and shake before use.
Methods of use and data statistics: the 15 persons filled out the corresponding questionnaires on the day of use, on the third day and after 1 week of continuous use.
The statistical results of the lotion state preference survey are as follows:
number of people who like No. 2 sample | The number of people who like No. 6 sample | Number of persons showing no relation to sample status | |
Day one | 6 | 8 | 1 |
The third day | 5 | 9 | 1 |
The seventh day | 5 | 9 | 1 |
The statistical results of the survey of the oil absorption effect preference of the toning lotion are shown in the following table:
number of people considering that No. 2 sample has good oil control effect | The number of people who think that No. 6 sample has good oil control effect | Number of people with no difference in oil control effect | |
Day one | 5 | 7 | 3 |
The third day | 6 | 7 | 2 |
The seventh day | 5 | 9 | 1 |
Among 15 volunteers, the number of people who developed allergy was 0.
According to the experimental result, the oil control effect of the No. 6 toning lotion is slightly better than that of the No. 2 toning lotion, and people who prefer the No. 6 toning lotion are slightly more than that of the No. 2 toning lotion. It can be seen that most people prefer the lotion prepared according to example 6, i.e., the lotion has the main components of 0.5-4.5% attapulgite, 5-15% alcohol and 0.05-0.2% salt, and the fast layering state and oil control effect of the lotion of example 6 are more popular, and are the preferred formula of the lotion of the present invention.
Although the present invention is disclosed above, the present invention is not limited thereto. Various changes and modifications may be effected therein by one skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (15)
1. A cosmetic lotion comprises a powder phase and an aqueous phase, wherein the powder phase is attapulgite, and the aqueous phase mainly contains water.
2. The lotion of claim 1, wherein said aqueous phase further comprises alcohol.
3. The astringent according to claim 2, wherein the alcohol is dideal alcohol.
4. The lotion according to any one of claims 1 to 3, wherein the aqueous phase further comprises a salt.
5. The lotion according to claim 4, wherein the salt is NaCl.
6. The astringent according to any one of claims 4 to 5, wherein the content of attapulgite is 0.5 to 4.5%, the content of alcohol is 5 to 15%, and the content of salt is 0.05 to 0.2%.
7. The lotion according to any one of claims 1-6, wherein the aqueous phase further comprises one or more of EDTA-2Na, glycerin, dipotassium glycyrrhizinate, dipropylene glycol, phenoxyethanol.
8. The lotion of claim 7, wherein the aqueous phase further comprises one or more of 0.05% EDTA-2Na, 3% glycerin, 0.05% dipotassium glycyrrhizinate, 1% dipropylene glycol, and 0.5% phenoxyethanol.
9. The lotion of claim 8, wherein the aqueous phase further comprises one or more of sodium hyaluronate, citric acid, and sodium citrate.
10. The lotion of claim 9, wherein the aqueous phase further comprises one or more of 0.1% sodium hyaluronate, 0.02% citric acid, and 0.3% sodium citrate.
11. Use of attapulgite in the manufacture of a skin oil control agent.
12. The use according to claim 11, wherein the agent comprises a powder phase and an aqueous phase, wherein the powder phase is attapulgite and the aqueous phase comprises water as a major component.
13. Use according to claim 12, wherein the aqueous phase further comprises alcohol.
14. Use according to any one of claims 12 to 13, wherein the aqueous phase further comprises a salt.
15. The use according to claim 14, wherein the content of attapulgite is 0.5-4.5%, the content of alcohol is 5-15%, and the content of salt is 0.05-0.2%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010165397.5A CN113384475A (en) | 2020-03-11 | 2020-03-11 | Toning lotion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010165397.5A CN113384475A (en) | 2020-03-11 | 2020-03-11 | Toning lotion |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113384475A true CN113384475A (en) | 2021-09-14 |
Family
ID=77615321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010165397.5A Pending CN113384475A (en) | 2020-03-11 | 2020-03-11 | Toning lotion |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113384475A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118141700A (en) * | 2024-03-01 | 2024-06-07 | 广州青囊生物科技有限公司 | Oil-controlling and anti-inflammatory composition and preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727415A (en) * | 2012-06-18 | 2012-10-17 | 曾技 | Anti-allergic cosmetic and production process thereof |
CN104188877A (en) * | 2014-08-06 | 2014-12-10 | 明光市国星凹土有限公司 | Modified attapulgite with aroma and preparation method thereof |
CN106333918A (en) * | 2016-10-19 | 2017-01-18 | 刘艺鹏 | After-sun repair attapulgite face cream |
CN106676929A (en) * | 2016-12-09 | 2017-05-17 | 湖南御家化妆品制造有限公司 | Mineral skin-protecting oil-absorbing paper and preparation method thereof |
CN110772436A (en) * | 2019-11-05 | 2020-02-11 | 江苏清荷材料科技有限公司 | Skin-care oil-absorbing ball and preparation method thereof |
-
2020
- 2020-03-11 CN CN202010165397.5A patent/CN113384475A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727415A (en) * | 2012-06-18 | 2012-10-17 | 曾技 | Anti-allergic cosmetic and production process thereof |
CN104188877A (en) * | 2014-08-06 | 2014-12-10 | 明光市国星凹土有限公司 | Modified attapulgite with aroma and preparation method thereof |
CN106333918A (en) * | 2016-10-19 | 2017-01-18 | 刘艺鹏 | After-sun repair attapulgite face cream |
CN106676929A (en) * | 2016-12-09 | 2017-05-17 | 湖南御家化妆品制造有限公司 | Mineral skin-protecting oil-absorbing paper and preparation method thereof |
CN110772436A (en) * | 2019-11-05 | 2020-02-11 | 江苏清荷材料科技有限公司 | Skin-care oil-absorbing ball and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118141700A (en) * | 2024-03-01 | 2024-06-07 | 广州青囊生物科技有限公司 | Oil-controlling and anti-inflammatory composition and preparation method and application thereof |
CN118141700B (en) * | 2024-03-01 | 2024-09-10 | 广州青囊生物科技有限公司 | Oil-control anti-inflammatory composition and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220409513A1 (en) | Cosmetic composition for peel-off-type packs, and method for producing same | |
DE69618250T2 (en) | USE FOR COSMETIC PURPOSES OF A STIFF GEL, AND APPLIED COSMETIC AND DERMATOLOGICAL COMPOSITIONS | |
EP0887070B1 (en) | External composition for skin comprising sphingoglycolipid | |
CN106265360B (en) | Facial cleanser containing seaweed fermentation product and preparation method thereof | |
US6180122B1 (en) | Solid cosmetic composition and uses thereof | |
CN109350591B (en) | Dry facial mask for beautifying face and preparation method thereof | |
CN106726646A (en) | A kind of clarity oil-control matifying lotion and preparation method thereof | |
KR101908408B1 (en) | A cosmetic composition for skin desquamation comprising spicule powder and natural powder | |
CN106265339A (en) | A kind of six hours high-efficiency moisturizing compositions and preparation thereof and application | |
CN105310941A (en) | Mud mask containing Manicouagan glacier mud | |
CN106667847A (en) | Magnetic graphene composite material mask rich in hydrogen water | |
CN106214532B (en) | Composition and preparation method thereof with oil-control bacteriostasis efficacy | |
US6312702B2 (en) | Solid cosmetic composition free of fillers, containing low amounts of gelling agents | |
CN113384475A (en) | Toning lotion | |
CN108245454A (en) | A kind of rich results hydrating cleanser containing natural anti-oxidation ingredient and preparation method thereof | |
CN111631965A (en) | Plant-derived facial mask with cleaning and makeup removing functions | |
US20060198805A1 (en) | Cosmetic and Pharmaceutical Masks for Skin Improvement | |
CN106667854A (en) | Hydrating and whitening mask capable of accelerating damaged skin regeneration | |
KR102203167B1 (en) | Cosmetic composition that contains hydrolyzed sponge powder or spongy powder sealed on a lamella liquid crystal that has fast skin regeneration and improved skin and scalp | |
FR3060379B1 (en) | COMPOSITION COMPRISING A POLYMER OF AMPS, MONTMORILLONITE, SILICA AND KAOLIN | |
CN116509738A (en) | Compound anti-aging face cream and preparation method thereof | |
JPS63139108A (en) | Skin cosmetic | |
CN115554189A (en) | Hand cream containing crude extracellular polysaccharide of schizophyllum commune and preparation method thereof | |
CN109498520A (en) | Desquamation compositions, shampoo and preparation method thereof | |
JP3839390B2 (en) | Cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210914 |
|
RJ01 | Rejection of invention patent application after publication |